Please assess the completion status of the following clinical trial:

Trial Title: Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women between ages 18 through 80~* American Society of Anesthesiologists (ASA) level I, II and III~* External hemorrhoids must be present and deemed sufficiently symptomatic to warrant removal~* Internal hemorrhoids at least Grade II~* Must be able to be seen post-operatively by the surgeon at 3 to 4 weeks and 3 months after surgery~Exclusion Criteria:~* American Society of Anesthesiologists (ASA) level IV~* Grade I internal hemorrhoids~* Currently receiving coumadin, plavix, or other anticoagulants~* No prior sphincterotomy, drainage of abscess, fistulotomy, or similar procedures~* No pregnant women at the time of surgery~* No lactating women~* No inflammatory bowel disease~* No history of chronic, active hepatitis B, C, or HIV infection~* No prior chronic narcotic use (more than 30 days)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- EnSeal Device (Type: EXPERIMENTAL): EnSeal Trio Tissue Sealing Device

Based on this trial design, predict the completion outcome and termination type (if applicable).